STABLE Workplaces Aims to Create a Healthier Workforce; Seeks to Bring Resources Together hcpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcpress.com Daily Mail and Mail on Sunday newspapers.
A joint study to explore how genes can be edited to develop new drugs for cancer, neurodegeneration and other diseases being conducted in the UK by researchers in Dundee, was awarded £4. Click to read more.
Dr. Archa Fox is an Associate Professor and ARC Future Fellow in the School of Human Sciences and the School of Molecular Sciences at the University of Western Australia, and an affiliate with the Harry Perkins Institute of Medical Research. Archa completed her PhD with Professor Merlin Crossley (USYD, year 2000) on transcription factor interactions. She then carried out Postdoctoral work with Angus Lamond (Dundee, UK), where she discovered the paraspeckle, a new type of sub-nuclear body, built on a noncoding RNA. In 2006 she started her own research group at the (now) Harry Perkins Institute of Medical Research in WA. In 2015 she took up an academic position at the University of WA. Archa was given the emerging leader award of the Australian/NZ Society of Cell and Developmental Biology in 2017. She is treasurer of the Board of Lorne Genome Inc, President of the RNA Network of Australia and was recently elected as a Director of the Board for the RNA Society (2020-21).